Whole-Genome Sequencing of Pathogens

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

• Implement whole-genome sequencing for outbreak tracking by pairing validated DNA extraction with standardized bioinformatics pipelines for core genome multilocus sequence typing and single nucleotide polymorphism analysis.
• Establish a clear decision workflow that routes isolates to sequencing only after culture purity checks and species confirmation, with reference strains included in every run.
• Interpret genomic clustering alongside epidemiological data, because sequencing alone cannot prove transmission without case linkage and temporal context.

At a Glance

Scope of Bacterial Whole-Genome Sequencing

Whole-genome sequencing of bacterial pathogens has shifted from a research tool to a routine public health method for outbreak detection and surveillance. The technology reads the complete DNA sequence of an isolate, allowing laboratories to compare strains at the highest possible resolution. This approach has changed how public health microbiologists track foodborne illness, hospital-acquired infections, and antimicrobial-resistant organisms.

The practical value of WGS lies in its ability to distinguish between isolates that appear identical by traditional methods. For example, two isolates of the same species with the same biochemical profile may still differ by a handful of single nucleotide polymorphisms. Those differences can indicate whether the isolates share a recent common source or represent independent introductions. This resolution is the reason public health agencies have adopted WGS as a core tool for outbreak investigation.

The workflow spans several distinct stages. Each stage requires specific expertise, equipment, and quality controls. The stages include culture preparation, DNA extraction, library construction, sequencing, and bioinformatics analysis. A failure at any stage can compromise the final interpretation, so each step demands careful documentation and validation.

Public health laboratories operate under strict quality standards. The Bacteriological Analytical Manual from the U.S. Food and Drug Administration provides official methods for food microbiology that laboratories can adapt for sequencing workflows. These methods emphasize reproducibility and validation, which are equally important for genomic analysis.

Core Principles of Pathogen Sequencing

Resolution Beyond Traditional Typing

Traditional bacterial typing methods such as pulsed-field gel electrophoresis and multilocus sequence typing examine a limited portion of the genome. These methods can group isolates into broad categories but often lack the resolution to distinguish closely related strains. Whole-genome sequencing examines the complete genetic content of an organism, providing the highest available resolution for strain comparison.

This resolution matters for outbreak investigations. When a cluster of infections appears, public health officials need to know whether the cases share a common source. If isolates differ by only a few nucleotides, they likely share a recent common ancestor. If they differ by hundreds of nucleotides, they are probably unrelated. The threshold for relatedness varies by species and by the natural mutation rate of the organism.

Reference-Based and Reference-Free Approaches

Two main analytical approaches exist for comparing bacterial genomes. The first approach aligns sequencing reads to a reference genome. This method works well when a high-quality reference genome exists for the species. The second approach assembles reads into a new genome without a reference, then compares the assembled genomes to each other.

Reference-based approaches are faster and require less computational power. They work best for organisms with stable, well-characterized reference genomes. Reference-free approaches are more flexible but require more computational resources and careful quality control. Many laboratories use both approaches depending on the question being asked.

Core Genome and Pan Genome

The core genome consists of genes present in all isolates of a species. The pan genome includes all genes found across the species, including those present in only some isolates. For outbreak investigations, the core genome is often the most useful because it provides a stable basis for comparison.

Core genome multilocus sequence typing compares the alleles of core genes across isolates. This method provides a standardized approach for comparing isolates within a species. The method is reproducible across laboratories because it uses a defined set of genes. The approach is widely used for surveillance and outbreak detection.

The Outbreak Investigation Workflow

Step 1: Culture and Species Confirmation

The WGS workflow begins with a pure culture of the suspected pathogen. The culture must be free of contaminating organisms because mixed cultures produce unreliable sequence data. Laboratories should confirm the species identity using established methods before proceeding to sequencing.

The American Type Culture Collection provides authenticated reference strains that laboratories can use to validate their identification methods. These reference strains have known characteristics and can serve as positive controls. Using authenticated materials reduces the risk of misidentification and ensures that downstream results are reliable.

Step 2: DNA Extraction and Quality Assessment

DNA extraction must produce high-quality, high-molecular-weight DNA. The extraction method should be appropriate for the bacterial species being sequenced. Gram-positive organisms require more robust lysis methods than Gram-negative organisms because of their thicker cell walls.

After extraction, the laboratory must assess DNA quality. The key measurements are concentration, purity, and integrity. Concentration is typically measured by fluorometric methods. Purity is assessed by measuring the ratio of absorbance at 260 and 280 nanometers. Integrity is assessed by gel electrophoresis or automated fragment analysis.

The quality thresholds depend on the sequencing platform being used. Some platforms require higher molecular weight DNA than others. Laboratories should establish their own acceptance criteria based on the manufacturer recommendations and their own validation data.

Step 3: Library Preparation

Library preparation converts the extracted DNA into a format that the sequencing instrument can read. The process involves fragmenting the DNA, attaching adapters, and amplifying the fragments. The specific steps depend on the sequencing platform and the library preparation kit.

The library preparation step is a common source of errors. Index misassignment can occur when the barcodes that identify individual samples are read incorrectly. This error can cause a sample to be assigned to the wrong isolate. Laboratories should use unique dual indexes to reduce the risk of misassignment.

The library preparation should include a positive control with a known sequence. This control verifies that the entire workflow is functioning correctly. The control should be processed in the same way as the test samples.

Step 4: Sequencing

The sequencing run produces the raw data that will be analyzed. The choice of sequencing platform depends on the laboratory needs, including throughput, cost, and turnaround time. The sequencing run should be monitored for quality metrics, including cluster density and quality scores.

The coverage depth is an important consideration. Coverage refers to the average number of times each nucleotide is read. Higher coverage provides more confidence in the sequence but costs more. The required coverage depends on the intended analysis. For outbreak investigations, coverage of at least 30-fold is often recommended, but the exact requirement depends on the organism and the analysis method.

Step 5: Bioinformatics Analysis

Bioinformatics analysis converts the raw sequencing data into meaningful results. The analysis typically includes quality trimming, assembly, and variant calling. The specific steps depend on the analysis being performed.

The bioinformatics pipeline must be validated before it is used for outbreak investigations. The validation should include testing the pipeline with known samples and comparing the results to expected outcomes. The pipeline should be documented, including the software versions and parameters used.

The analysis should include quality metrics at each step. The raw reads should be assessed for quality. The assembled genome should be assessed for completeness and contamination. The variant calls should be assessed for confidence.

Bioinformatics Analysis for Outbreak Tracking

Read Quality Assessment

The first step in bioinformatics analysis is assessing the quality of the raw sequencing reads. This assessment identifies reads that are low quality or contain adapter sequences. These reads should be trimmed or removed before further analysis.

The quality assessment should be documented for each sample. The documentation should include the number of reads, the quality scores, and the number of reads removed during trimming. This documentation is essential for reproducibility and for troubleshooting.

Genome Assembly

Genome assembly reconstructs the bacterial genome from the sequencing reads. The assembly can be performed using a reference-based approach or a de novo approach. The reference-based approach aligns reads to a known genome. The de novo approach assembles reads without a reference.

The quality of the assembly should be assessed using metrics such as the number of contigs and the total assembly size. The assembly should be compared to the expected genome size for the species. A highly fragmented assembly may indicate a problem with the DNA quality or the sequencing run.

Variant Calling and Comparison

Variant calling identifies the differences between the isolate and a reference genome. These variants are the basis for comparing isolates. The variants can be used to construct a phylogenetic tree that shows the relationships between isolates.

The variant calling should be performed with a validated pipeline. The pipeline should include filters to remove low-quality variants. The filters should be documented and consistent across runs.

The comparison of isolates should be interpreted in the context of the organism mutation rate. Organisms with high mutation rates will accumulate differences more quickly than organisms with low mutation rates. The interpretation should also consider the time frame of the outbreak.

Quality Controls and Validation

Positive and Negative Controls

Every sequencing run should include positive and negative controls. The positive control is a sample with a known sequence. The negative control is a sample that should not contain any DNA. The negative control detects contamination in the reagents or the workflow.

The positive control should be processed through the entire workflow, from extraction to sequencing. This control verifies that each step is functioning correctly. The negative control should be processed in the same way to detect contamination.

Reference Materials

Reference materials are essential for validating the WGS workflow. The American Type Culture Collection provides authenticated bacterial strains with known genome sequences. These strains can be used to validate the extraction, library preparation, sequencing, and bioinformatics steps.

The reference materials should be used to establish the baseline performance of the workflow. The results from the reference materials should be compared to the expected results. Any discrepancy should be investigated before the workflow is used for outbreak investigations.

Reproducibility Testing

The workflow should be tested for reproducibility. The same sample should be processed multiple times to ensure that the results are consistent. The reproducibility testing should include the entire workflow, from extraction to bioinformatics.

The reproducibility testing should be documented. The documentation should include the results from each replicate and the variation between replicates. The variation should be within an acceptable range.

Bioinformatics Tools and Databases

Public Databases for Comparison

Public databases provide a reference for comparing isolates. These databases contain genome sequences from isolates collected from around the world. The databases allow laboratories to compare their isolates to a broader population.

The databases are maintained by public health organizations and research institutions. The databases are updated regularly with new sequences. The databases are essential for understanding the context of an outbreak.

Software Pipelines

The bioinformatics analysis requires specialized software. The software is available from public health organizations and academic institutions. The software is designed to perform the specific steps of the analysis.

The software should be validated before use. The validation should include testing with known datasets. The software should be documented, including the version and the parameters used.

Data Storage and Sharing

The sequencing data should be stored in a secure and organized manner. The data should be backed up to prevent loss. The data should be shared with relevant public health authorities.

The data sharing should follow the applicable regulations and policies. The data should be shared in a format that is compatible with the receiving system. The data should be shared in a timely manner to support the outbreak investigation.

Common Failure Patterns

Contamination

Contamination is a common cause of failed sequencing runs. The contamination can occur at any stage of the workflow. The contamination can be detected by the negative controls.

The contamination can be caused by the reagents, the equipment, or the environment. The contamination can be reduced by following good laboratory practices. The contamination should be investigated when it is detected.

Low Quality DNA

Low quality DNA is a common cause of failed sequencing runs. The low quality DNA can be caused by the extraction method or the storage conditions. The low quality DNA can be detected by the quality assessment.

The low quality DNA can be improved by optimizing the extraction method. The low quality DNA can be prevented by storing the DNA under the appropriate conditions.

Index Misassignment

Index misassignment is a common cause of incorrect results. The index misassignment occurs when the barcodes are read incorrectly. The index misassignment can be reduced by using unique dual indexes.

The index misassignment can be detected by the positive control. The index misassignment should be investigated when it occurs.

Insufficient Coverage

Insufficient coverage is a common cause of unreliable results. The insufficient coverage can be caused by the sequencing run or the library preparation. The insufficient coverage can be detected by the quality assessment.

The insufficient coverage can be improved by increasing the sequencing depth. The insufficient coverage can be prevented by optimizing the library preparation.

Antimicrobial Resistance Surveillance

The Global Context

Antimicrobial resistance is a global public health threat. The World Health Organization has identified antimicrobial resistance as a priority for action. The WHO coordinates global surveillance of antimicrobial resistance and promotes stewardship of antimicrobial use.

Whole-genome sequencing is a powerful tool for antimicrobial resistance surveillance. The sequencing can identify the genes that confer resistance. The sequencing can also identify the mechanisms of resistance.

The Role of WGS in Resistance Detection

Whole-genome sequencing can detect the genes that confer antimicrobial resistance. The sequencing can identify the specific mutations that confer resistance. The sequencing can also identify the mobile genetic elements that spread resistance genes.

The sequencing results should be interpreted in the context of the antimicrobial susceptibility testing. The sequencing results should be confirmed by the phenotypic testing. The sequencing results should be used to guide the public health response.

The Limitations of WGS for Resistance

The WGS has limitations for antimicrobial resistance detection. The sequencing can identify the resistance genes but cannot determine the expression of the genes. The sequencing cannot determine the resistance phenotype.

The WGS results should be interpreted with caution. The WGS results should be confirmed by the phenotypic testing. The WGS results should be used in the context of the clinical situation.

Biosafety and Containment

Risk Assessment

The WGS workflow involves the handling of bacterial pathogens. The risk assessment should be performed before the work begins. The risk assessment should consider the pathogen, the procedures, and the laboratory.

The risk assessment should be documented. The risk assessment should be reviewed regularly. The risk assessment should be updated when the procedures change.

Containment Levels

The containment levels are defined by the biosafety guidelines. The containment levels are based on the risk of the pathogen. The containment levels are described in the Biosafety in Microbiological and Biomedical Laboratories guidelines.

The laboratory should follow the containment requirements for the pathogen. The laboratory should be designed to meet the containment requirements. The laboratory should be operated in accordance with the containment requirements.

Decontamination

The decontamination is an important part of the biosafety program. The decontamination should be performed after the work is complete. The decontamination should be performed using the appropriate methods.

The decontamination should be documented. The decontamination should be verified. The decontamination should be performed in accordance with the biosafety guidelines.

Records and Documentation

The Importance of Documentation

The documentation is essential for the WGS workflow. The documentation should include the details of the workflow. The documentation should include the results of the quality controls.

The documentation should be organized and accessible. The documentation should be stored in a secure location. The documentation should be retained for the appropriate period.

The Records to Keep

The records should include the details of the sample. The records should include the details of the extraction. The records should include the details of the library preparation.

The records should include the details of the sequencing run. The records should include the details of the bioinformatics analysis. The records should include the results of the quality controls.

The Use of Records

The records should be used to support the outbreak investigation. The records should be used to demonstrate the quality of the results. The records should be used to improve the workflow.

The records should be shared with the relevant public health authorities. The records should be shared in a timely manner. The records should be shared in a format that is compatible with the receiving system.

Professional Escalation Criteria

When to Escalate

The laboratory should escalate the results when the results are unexpected. The laboratory should escalate the results when the results are inconsistent. The laboratory should escalate the results when the results are not reproducible.

The laboratory should escalate the results when the quality control fails. The laboratory should escalate the results when the contamination is detected. The laboratory should escalate the results when the index misassignment is detected.

How to Escalate

The escalation should be performed in a timely manner. The escalation should be performed through the appropriate channels. The escalation should include the relevant information.

The escalation should include the details of the sample. The escalation should include the details of the workflow. The escalation should include the results of the quality controls.

The Role of the Laboratory

The laboratory has a role in the outbreak investigation. The laboratory should provide the results in a timely manner. The laboratory should provide the results in a format that is the appropriate.

The laboratory should provide the results in the context of the outbreak. The laboratory should provide the results in the context of the epidemiological data. The laboratory should provide the results in the context of the public health situation.

Decision Framework for Sequencing Versus Alternative Methods

Public health laboratories face a recurring operational question that precedes any wet bench work: should this isolate be sequenced at all? The decision to route an isolate into whole-genome sequencing carries real costs in reagents, instrument time, analyst effort, and bioinformatics capacity. A laboratory that sequences every isolate without a structured decision process will exhaust resources on samples that do not require genomic resolution. A laboratory that sequences too few isolates will miss outbreak linkages that traditional methods cannot detect. This section provides a practical decision framework that public health microbiologists can adapt to their own laboratory context, with explicit criteria for when sequencing adds value and when it does not.

The Triage Question Set

Before any isolate enters the sequencing workflow, the laboratory should apply a consistent triage question set. These questions are designed to be answered from existing laboratory records and epidemiological data. The answers determine whether the isolate proceeds to sequencing, waits for additional information, or is handled by traditional methods alone.

The first question concerns the epidemiological context. Is the isolate part of a suspected outbreak, a confirmed cluster, or a routine surveillance sample? An isolate from a suspected outbreak with multiple cases linked by time and place has a strong indication for sequencing. A routine surveillance isolate with no epidemiological signal may not require genomic analysis. The second question concerns the species and its known mutation rate. Organisms with high mutation rates accumulate differences quickly, so the threshold for genomic relatedness is different from organisms with low mutation rates. The third question concerns the results of traditional typing. If pulsed-field gel electrophoresis or multilocus sequence typing has already distinguished the isolate from other cases, sequencing may not add useful information. If traditional methods show the isolates are indistinguishable, sequencing is the appropriate next step.

The fourth question concerns the public health action that would follow the result. Sequencing is justified when the result will change an investigation, such as confirming a common source, ruling out a suspected link, or identifying a contaminated product. Sequencing is harder to justify when the result will not alter the public health response. The fifth question concerns the laboratory capacity. The laboratory must have validated methods, available instrument time, and trained staff to complete the workflow. A laboratory that is at capacity should prioritize isolates with the strongest epidemiological indication.

The Decision Matrix

The decision matrix below organizes the triage criteria into a practical tool. The matrix uses three levels of indication: sequence, consider sequencing, and do not sequence. The levels are based on the combination of epidemiological context and traditional typing results.

The matrix is a starting point, not a substitute for professional judgment. The laboratory should document the reason for each sequencing decision. The documentation should include the epidemiological context, the traditional typing result, and the rationale for the decision. This documentation supports the outbreak investigation and provides a record for quality audits.

The Cost and Benefit Calculation

The decision framework must account for the cost of sequencing and the benefit of the result. The cost includes the reagents, the instrument time, the analyst time, and the bioinformatics time. The benefit includes the public health action that the result enables. The benefit is difficult to quantify, but the laboratory can use a simple calculation to support the decision.

The calculation starts with the number of isolates in the suspected cluster. The laboratory estimates the probability that the isolates share a common source based on the epidemiological data. The laboratory then estimates the probability that sequencing will change the public health response. The product of these probabilities is the expected benefit of sequencing. If the expected benefit exceeds the cost, the sequencing is justified.

The calculation is not a formal cost-benefit analysis. It is a structured way to think about the decision. The laboratory should document the calculation for each isolate or cluster. The documentation should include the assumptions and the data used. The documentation should be reviewed by the laboratory supervisor or the public health epidemiologist.

The Role of Traditional Methods in the Decision

Traditional typing methods remain important in the decision framework. The methods are faster and less expensive than sequencing. The methods are also well established and validated. The laboratory should use traditional methods as the first line of analysis for most isolates.

The traditional methods are particularly useful for the initial screening of a suspected outbreak. The methods can quickly identify whether the isolates are distinguishable. If the isolates are distinguishable, the outbreak may involve multiple sources. If the isolates are indistinguishable, the outbreak may involve a single source and sequencing is the appropriate next step.

The traditional methods are also useful for the confirmation of the sequencing results. The sequencing results should be consistent with the traditional results. A discrepancy between the methods should be investigated. The discrepancy may indicate a problem with the sequencing or a problem with the traditional method.

The Decision Record System

The decision framework requires a record system that captures the triage criteria, the decision, and the rationale. The record system should be simple and practical. The record system should be integrated into the laboratory information management system or a spreadsheet.

The record should include the following fields: the isolate identifier, the species, the date of isolation, the epidemiological context, the traditional typing result, the sequence indicator, the decision, the rationale, and the name of the analyst. The record should also include the date of the decision and the date of the sequencing, if applicable.

The record system should be reviewed regularly. The review should identify the patterns in the decisions. The review should identify the isolates that were sequenced but did not produce a public health action. The review should identify the isolates that were not sequenced but later were linked to an outbreak. The review should be used to improve the decision framework.

The Escalation Criteria for the Decision

The decision framework includes escalation criteria. The laboratory should escalate the decision when the isolate is part of a large outbreak, when the isolate is from a vulnerable population, or when the isolate is from a novel or unusual source. The escalation should be performed through the appropriate channels.

The escalation should include the isolate information, the traditional typing result, the epidemiological context, and the proposed decision. The escalation should be documented. The escalation should be reviewed by the laboratory supervisor or the public health epidemiologist.

The escalation criteria are not a substitute for the decision framework. The escalation criteria are a way to ensure that the important decisions receive the appropriate attention. The escalation criteria should be applied consistently.

The Comparison of Sequencing Platforms

The decision framework also includes the comparison of sequencing platforms. The laboratory must choose the platform that meets the needs of the outbreak investigation. The needs include the throughput, the cost, the turnaround time, and the quality of the data.

The comparison should be based on the validation data. The laboratory should test the platform with the reference materials. The laboratory should compare the results to the expected results. The laboratory should document the comparison.

The comparison should include the following factors: the read length, the accuracy, the throughput, the cost per sample, the turnaround time, and the ease of use. The factors should be weighted according to the laboratory needs. The comparison should be reviewed by the laboratory team.

The Validation of the Decision Framework

The decision framework should be validated before it is used for outbreak investigations. The validation should include testing the framework with known samples. The validation should include comparing the decisions to the expected outcomes. The validation should be documented.

The validation should include the reference materials from the American Type Culture Collection. The reference materials have known characteristics and can be used to test the decision framework. The validation should include the isolates from the previous outbreaks. The validation should include the isolates that were sequenced and the isolates that were not sequenced.

The validation should be repeated when the framework is changed. The validation should be repeated when the laboratory methods are changed. The validation should be repeated when the epidemiological context changes.

The Integration with the Public Health Response

The decision framework is not a standalone tool. The framework is integrated with the public health response. The laboratory should work with the epidemiologist to apply the framework. The laboratory should provide the results to the epidemiologist in a timely manner.

The integration should include the regular meetings between the laboratory and the epidemiology team. The meetings should review the isolates that are being considered for sequencing. The meetings should review the results of the sequencing. The meetings should review the public health actions that are being taken.

The integration should include the sharing of the data. The laboratory should share the sequencing results with the epidemiology team. The epidemiology team should share the epidemiological data with the laboratory. The sharing should be done in a secure and organized manner.

The Common Failure Patterns in the Decision

The decision framework has common failure patterns. The first pattern is the overuse of sequencing. The laboratory sequences every isolate without applying the triage criteria. This pattern wastes resources and delays the results for the isolates that need sequencing.

The second pattern is the underuse of sequencing. The laboratory does not sequence the isolates that need genomic resolution. This pattern misses the outbreak linkages and delays the public health response.

The third pattern is the inconsistent application of the decision framework. The laboratory applies the framework inconsistently across the analysts. This pattern produces the results that are not reproducible and the decisions that are not defensible.

The fourth pattern is the failure to document the decision. The laboratory makes the decision without recording the rationale. This pattern makes it difficult to review the decision and to improve the framework.

The failure patterns can be addressed by the training and the review. The laboratory should train the analysts on the decision framework. The laboratory should review the decisions regularly. The laboratory should use the review to improve the framework.

The Professional Escalation Criteria for the Decision

The decision framework includes the professional escalation criteria. The laboratory should escalate the decision when the isolate is from a novel pathogen, when the isolate is from a vulnerable population, or when the isolate is part of a large outbreak. The escalation should be performed in a timely manner.

The escalation should include the isolate identifier, the epidemiological context, the traditional result, and the proposed decision. The escalation should be reviewed by the laboratory supervisor or the public health epidemiologist. The escalation should be documented.

The escalation should be performed through the appropriate channels. The channels should be defined in the laboratory quality manual. The channels should be reviewed regularly. The channels should be updated when the laboratory structure changes.

The Records and Measurements for the Decision

The decision framework requires the records and the measurements. The records should include the decision for each isolate. The records should include the rationale for the decision. The records should include the results of the review.

The measurements should include the number of isolates sequenced, the number of isolates not sequenced, the number of isolates that produced a public health action, and the number of isolates that did not produce a public health action. The measurements should be reviewed regularly.

The measurements should be used to improve the decision framework. The measurements should be used to identify the patterns in the decisions. The measurements should be used to identify the areas for improvement.

The Professional Context

The decision framework is part of the professional practice of public health microbiology. The American Society for Microbiology provides the professional context for the laboratory practice. The society provides the education and the training for the laboratory workforce. The society provides the standards for the professional practice.

The decision framework is also part of the global context for the antimicrobial resistance surveillance. The World Health Organization coordinates the global surveillance of the antimicrobial resistance. The WHO promotes the stewardship of the antimicrobial use. The WHO provides the context for the public health response.

The decision framework is also part of the quality context for the food microbiology. The Bacteriological Analytical Manual from the U.S. Food and Drug Administration provides the official methods for the food microbiology. The manual emphasizes the reproducibility and the validation. The decision framework should be consistent with the quality principles.

The Practical Implementation Steps

The laboratory should implement the decision framework in a structured manner. The implementation should include the following steps.

The first step is to review the existing workflow. The laboratory should identify the current decision points. The laboratory should identify the current criteria. The laboratory should identify the current documentation.

The second step is to adapt the decision framework to the laboratory context. The laboratory should modify the triage criteria to the local epidemiology. The laboratory should modify the cost calculation to the local costs. The laboratory should modify the record system to the local workflow.

The third step is to train the analysts. The laboratory should train the analysts on the decision framework. The training should include the case studies. The training should include the common failure patterns. The training should include the escalation criteria.

The fourth step is to pilot the framework. The laboratory should test the framework on a small set of isolates. The laboratory should review the results. The laboratory should modify the framework based on the results.

The fifth step is to implement the framework. The laboratory should implement the framework in the full workflow. The laboratory should monitor the results. The laboratory should review the results regularly.

The sixth step is to review the framework. The laboratory should review the framework on a regular basis. The laboratory should review the measurements. The laboratory should review the failure patterns. The laboratory should update the framework as needed.

The implementation should be documented. The documentation should include the review of the workflow, the adaptation of the framework, the training of the analysts, the pilot of the framework, the implementation of the framework, and the review of the framework. The documentation should be stored in a secure location.

The Records and Measurements for the Decision Framework

The records for the decision framework should be organized and accessible. The records should include the decision for each isolate. The records should include the rationale for the decision. The records should include the review of the decision.

The measurements for the decision framework should be collected on a regular basis. The measurements should include the number of isolates sequenced, the number of isolates not sequenced, the number of isolates that produced a public health action, and the number of isolates that did not produce a public health action. The measurements should include the turnaround time for the sequencing and the cost per isolate.

The measurements should be used to improve the decision framework. The measurements should be reviewed by the laboratory team. The measurements should be used to identify the patterns in the decisions. The measurements should be used to identify the areas for improvement.

The records and the measurements should be shared with the relevant public health authorities. The sharing should be done in a timely manner. The sharing should be done in a format that is compatible with the receiving system. The sharing should be done in accordance with the applicable regulations and policies.

The Professional Escalation Criteria for the Decision Framework

The professional escalation criteria for the decision framework should be documented. The escalation should be performed when the isolate is uncertain, when the result is inconsistent, or when the result is not reproducible. The escalation should be performed when the quality control fails.

The escalation should be performed through the appropriate channels. The channels should be documented in the laboratory quality manual. The escalation should include the isolate identifier, the epidemiological context, the traditional result, and the proposed decision. The escalation should include the rationale for the escalation.

The escalation should be reviewed by the laboratory supervisor or the public health epidemiologist. The review should be documented. The review should include the decision and the rationale. The review should be used to improve the decision framework.

The laboratory has a role in the outbreak investigation. The laboratory should provide the results in a timely manner. The laboratory should provide the results in a format that is appropriate. The laboratory should provide the results in the context of the epidemiological data. The laboratory should provide the results in the context of the public health situation.

Frequently Asked Questions

What is the difference between whole-genome sequencing and traditional typing methods?

Whole-genome sequencing examines the entire genetic content of a bacterial isolate, while traditional typing methods such as pulsed-field gel electrophoresis or serotyping examine only a limited portion of the genome. This means WGS provides a much higher resolution for distinguishing between closely related isolates. The higher resolution allows public health laboratories to identify the source of an outbreak with greater confidence.

How long does the whole-genome sequencing workflow take?

The time required for the WGS workflow depends on the specific steps and the laboratory capacity. The culture and extraction steps typically take one to two days. The library preparation and sequencing take an additional one to two days. The bioinformatics analysis can take several hours to a day. The total time from culture to result is typically three to five days.

What is the minimum coverage depth for outbreak investigation?

The minimum coverage depth depends on the analysis being performed and the organism being studied. For most outbreak investigations, a coverage depth of at least 30-fold is recommended. This depth provides enough data for reliable variant calling. The exact requirement should be validated by the laboratory.

How do I know if my sequencing results are reliable?

The reliability of the sequencing results is determined by the quality controls. The quality controls include the positive and negative controls, the quality assessment of the DNA, and the quality assessment of the sequencing run. The results should be reproducible across replicates. The results should be consistent with the expected results for the reference materials.

Can whole-genome sequencing detect antimicrobial resistance?

Whole-genome sequencing can identify the genetic determinants of antimicrobial resistance. The sequencing can identify the resistance genes and the mutations that confer resistance. However, the sequencing cannot determine the phenotypic resistance. The sequencing results should be confirmed by the antimicrobial susceptibility testing.

What are the common causes of failed sequencing runs?

The common causes of failed sequencing runs include contamination, low quality DNA, and index misassignment. The contamination can be detected by the negative control. The low quality DNA can be detected by the quality assessment. The index misassignment can be detected by the positive control.

How do I choose the right sequencing platform?

The choice of the sequencing platform depends on the laboratory needs. The needs include the throughput, the cost, and the turnaround time. The choice should be based on the validation data and the intended use. The choice should be made in the context of the laboratory capacity.

What is the role of the reference genome in the analysis?

The reference genome provides a basis for the comparison of the isolates. The reference genome is used for the alignment of the sequencing reads. The reference genome is used for the variant calling. The choice of the reference genome should be appropriate for the species being studied.

Related Bacteriology Guides

• Bacterial Carriage in Ducks: Pathogens of Public Health Concern
• Bacterial Pathogens in Chicken Meat: Risk Assessment and Public Health Impact
• Chicken Bacteria Food Poisoning: Pathogens, Clinical Syndromes, and Public Health Implications
• Salmonellosis and Colibacillosis in Poultry: Bacterial Pathogens, Public Health Implications, and Control Strategies
• Bacterial Foodborne Pathogens in Poultry: Salmonella and Escherichia coli in Chickens, Clinical and Public Health Perspectives

References and Further Reading

• Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
• Microbiology Resources. American Society for Microbiology.
• Antimicrobial Resistance. World Health Organization.
• Bacteriological Analytical Manual. U.S. Food and Drug Administration.
• Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
• Culture Collections. American Type Culture Collection.
• NCBI Pathogen Detection. National Center for Biotechnology Information.
• Genomic Epidemiology: Whole-Genome-Sequencing-Powered Surveillance and Outbreak Investigation of Foodborne Bacterial Pathogens.. Annual review of food science and technology, 2016.
• Whole genome sequencing of carbapenem-resistant Klebsiella pneumoniae: evolutionary analysis for outbreak investigation.. Future microbiology, 2020.
• SARS-CoV-2 Outbreak Investigation Using Contact Tracing and Whole-Genome Sequencing in an Ontario Tertiary Care Hospital.. Microbiology spectrum, 2023.
• Interpreting whole-genome sequencing data during neonatal Klebsiella oxytoca complex outbreak management.. Antimicrobial resistance and infection control, 2025.

This article is educational and does not replace validated laboratory procedures, clinical diagnosis, institutional biosafety review, or public-health guidance.